Loading…
Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice
Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral ne...
Saved in:
Published in: | Journal of Pharmacological Sciences 2014/07/20, Vol.125(3), pp.292-299 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963 |
---|---|
cites | cdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963 |
container_end_page | 299 |
container_issue | 3 |
container_start_page | 292 |
container_title | Journal of Pharmacological Sciences |
container_volume | 125 |
creator | Ohsawa, Masahiro Otake, Saki Murakami, Tomoyasu Yamamoto, Shohei Makino, Toshiaki Ono, Hideki |
description | Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ. |
doi_str_mv | 10.1254/jphs.14058FP |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_abc7682753dc40b291600e86a2ad490f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319301239</els_id><doaj_id>oai_doaj_org_article_abc7682753dc40b291600e86a2ad490f</doaj_id><sourcerecordid>1547830321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</originalsourceid><addsrcrecordid>eNqFUk1v1DAQjRCIlsKNM8qRA1vGH7GdIyp0u1Kr9gBna-JMtl5lk2BnK_rvcTbbnJC4jK2Z5zcz7znLPjK4ZLyQX3fDY7xkEgpz_fAqO2dC6pVR0rxe7kycZe9i3AFwA0y9zc64LEtgrDjP1muscKBu9F3-EOgp3WJ-_wdbP7SYkqtNVx8c1fkduUfsvMM2v3keKGC7pegxT-_uvKP32ZsG20gfTudF9uv6x8-rm9Xt_Xpz9e125bSW46risii0Jq4dGoBKGdSShCQOZcNko1UtXMWJqqrijUZkjQSjGlUjCiyVuMg2M2_d484Owe8xPNsevT0m-rC1GEbvWrJYOa0M14WonYSKl0wBkFHIsZYlNInr88w1hP73geJo9z46alvsqD9Ey5SZCBQv_g8tpDYCBGcJ-mWGutDHGKhZpmRgJ8fs5Jg9OZbgn07Mh2pP9QJ-sSgB1jMgVSf5-671HdldfwhdUtq6RkXnqbMcmLSQOoCwANoCL_kUSp5Wh2LS7vvMtIsjbmlp9SLYPBcvrDjG04RLOfkfLHWJRs00lHx-8hTssX_6JD6QG5MR_t-r_gUQ_dIA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547830321</pqid></control><display><type>article</type><title>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</title><source>ScienceDirect Journals</source><creator>Ohsawa, Masahiro ; Otake, Saki ; Murakami, Tomoyasu ; Yamamoto, Shohei ; Makino, Toshiaki ; Ono, Hideki</creator><creatorcontrib>Ohsawa, Masahiro ; Otake, Saki ; Murakami, Tomoyasu ; Yamamoto, Shohei ; Makino, Toshiaki ; Ono, Hideki ; Musashino University ; Department of Pharmacognosy ; Graduate School of Pharmaceutical Sciences ; Nagoya City University ; Laboratory of Clinical Pharmacy and Pharmacology ; Faculty of Pharmacy ; Laboratory of CNS Pharmacology</creatorcontrib><description>Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.14058FP</identifier><identifier>PMID: 24990115</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject><![CDATA[Actin Depolymerizing Factors - metabolism ; Amines - administration & dosage ; Amines - pharmacology ; Animals ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; cofilin ; Cold Temperature - adverse effects ; Cyclohexanecarboxylic Acids - administration & dosage ; Cyclohexanecarboxylic Acids - pharmacology ; Gabapentin ; gamma-Aminobutyric Acid - administration & dosage ; gamma-Aminobutyric Acid - pharmacology ; Hyperalgesia - chemically induced ; Hyperalgesia - metabolism ; Hyperalgesia - prevention & control ; Injections, Intraperitoneal ; Male ; mechanical allodynia ; Mice, Inbred Strains ; neuropathic pain ; Organoplatinum Compounds - administration & dosage ; Organoplatinum Compounds - adverse effects ; Oxaliplatin ; Phosphorylation - drug effects ; Spinal Cord - metabolism]]></subject><ispartof>Journal of Pharmacological Sciences, 2014/07/20, Vol.125(3), pp.292-299</ispartof><rights>2014 Copyright Elsevier B.V.</rights><rights>2014 The Japanese Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</citedby><cites>FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319301239$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24990115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohsawa, Masahiro</creatorcontrib><creatorcontrib>Otake, Saki</creatorcontrib><creatorcontrib>Murakami, Tomoyasu</creatorcontrib><creatorcontrib>Yamamoto, Shohei</creatorcontrib><creatorcontrib>Makino, Toshiaki</creatorcontrib><creatorcontrib>Ono, Hideki</creatorcontrib><creatorcontrib>Musashino University</creatorcontrib><creatorcontrib>Department of Pharmacognosy</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Nagoya City University</creatorcontrib><creatorcontrib>Laboratory of Clinical Pharmacy and Pharmacology</creatorcontrib><creatorcontrib>Faculty of Pharmacy</creatorcontrib><creatorcontrib>Laboratory of CNS Pharmacology</creatorcontrib><title>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ.</description><subject>Actin Depolymerizing Factors - metabolism</subject><subject>Amines - administration & dosage</subject><subject>Amines - pharmacology</subject><subject>Animals</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>cofilin</subject><subject>Cold Temperature - adverse effects</subject><subject>Cyclohexanecarboxylic Acids - administration & dosage</subject><subject>Cyclohexanecarboxylic Acids - pharmacology</subject><subject>Gabapentin</subject><subject>gamma-Aminobutyric Acid - administration & dosage</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Hyperalgesia - chemically induced</subject><subject>Hyperalgesia - metabolism</subject><subject>Hyperalgesia - prevention & control</subject><subject>Injections, Intraperitoneal</subject><subject>Male</subject><subject>mechanical allodynia</subject><subject>Mice, Inbred Strains</subject><subject>neuropathic pain</subject><subject>Organoplatinum Compounds - administration & dosage</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Oxaliplatin</subject><subject>Phosphorylation - drug effects</subject><subject>Spinal Cord - metabolism</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFUk1v1DAQjRCIlsKNM8qRA1vGH7GdIyp0u1Kr9gBna-JMtl5lk2BnK_rvcTbbnJC4jK2Z5zcz7znLPjK4ZLyQX3fDY7xkEgpz_fAqO2dC6pVR0rxe7kycZe9i3AFwA0y9zc64LEtgrDjP1muscKBu9F3-EOgp3WJ-_wdbP7SYkqtNVx8c1fkduUfsvMM2v3keKGC7pegxT-_uvKP32ZsG20gfTudF9uv6x8-rm9Xt_Xpz9e125bSW46risii0Jq4dGoBKGdSShCQOZcNko1UtXMWJqqrijUZkjQSjGlUjCiyVuMg2M2_d484Owe8xPNsevT0m-rC1GEbvWrJYOa0M14WonYSKl0wBkFHIsZYlNInr88w1hP73geJo9z46alvsqD9Ey5SZCBQv_g8tpDYCBGcJ-mWGutDHGKhZpmRgJ8fs5Jg9OZbgn07Mh2pP9QJ-sSgB1jMgVSf5-671HdldfwhdUtq6RkXnqbMcmLSQOoCwANoCL_kUSp5Wh2LS7vvMtIsjbmlp9SLYPBcvrDjG04RLOfkfLHWJRs00lHx-8hTssX_6JD6QG5MR_t-r_gUQ_dIA</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Ohsawa, Masahiro</creator><creator>Otake, Saki</creator><creator>Murakami, Tomoyasu</creator><creator>Yamamoto, Shohei</creator><creator>Makino, Toshiaki</creator><creator>Ono, Hideki</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>DOA</scope></search><sort><creationdate>2014</creationdate><title>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</title><author>Ohsawa, Masahiro ; Otake, Saki ; Murakami, Tomoyasu ; Yamamoto, Shohei ; Makino, Toshiaki ; Ono, Hideki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Actin Depolymerizing Factors - metabolism</topic><topic>Amines - administration & dosage</topic><topic>Amines - pharmacology</topic><topic>Animals</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>cofilin</topic><topic>Cold Temperature - adverse effects</topic><topic>Cyclohexanecarboxylic Acids - administration & dosage</topic><topic>Cyclohexanecarboxylic Acids - pharmacology</topic><topic>Gabapentin</topic><topic>gamma-Aminobutyric Acid - administration & dosage</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Hyperalgesia - chemically induced</topic><topic>Hyperalgesia - metabolism</topic><topic>Hyperalgesia - prevention & control</topic><topic>Injections, Intraperitoneal</topic><topic>Male</topic><topic>mechanical allodynia</topic><topic>Mice, Inbred Strains</topic><topic>neuropathic pain</topic><topic>Organoplatinum Compounds - administration & dosage</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Oxaliplatin</topic><topic>Phosphorylation - drug effects</topic><topic>Spinal Cord - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohsawa, Masahiro</creatorcontrib><creatorcontrib>Otake, Saki</creatorcontrib><creatorcontrib>Murakami, Tomoyasu</creatorcontrib><creatorcontrib>Yamamoto, Shohei</creatorcontrib><creatorcontrib>Makino, Toshiaki</creatorcontrib><creatorcontrib>Ono, Hideki</creatorcontrib><creatorcontrib>Musashino University</creatorcontrib><creatorcontrib>Department of Pharmacognosy</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Nagoya City University</creatorcontrib><creatorcontrib>Laboratory of Clinical Pharmacy and Pharmacology</creatorcontrib><creatorcontrib>Faculty of Pharmacy</creatorcontrib><creatorcontrib>Laboratory of CNS Pharmacology</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>DOAJÂ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohsawa, Masahiro</au><au>Otake, Saki</au><au>Murakami, Tomoyasu</au><au>Yamamoto, Shohei</au><au>Makino, Toshiaki</au><au>Ono, Hideki</au><aucorp>Musashino University</aucorp><aucorp>Department of Pharmacognosy</aucorp><aucorp>Graduate School of Pharmaceutical Sciences</aucorp><aucorp>Nagoya City University</aucorp><aucorp>Laboratory of Clinical Pharmacy and Pharmacology</aucorp><aucorp>Faculty of Pharmacy</aucorp><aucorp>Laboratory of CNS Pharmacology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2014</date><risdate>2014</risdate><volume>125</volume><issue>3</issue><spage>292</spage><epage>299</epage><pages>292-299</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>24990115</pmid><doi>10.1254/jphs.14058FP</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-8613 |
ispartof | Journal of Pharmacological Sciences, 2014/07/20, Vol.125(3), pp.292-299 |
issn | 1347-8613 1347-8648 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_abc7682753dc40b291600e86a2ad490f |
source | ScienceDirect Journals |
subjects | Actin Depolymerizing Factors - metabolism Amines - administration & dosage Amines - pharmacology Animals Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects cofilin Cold Temperature - adverse effects Cyclohexanecarboxylic Acids - administration & dosage Cyclohexanecarboxylic Acids - pharmacology Gabapentin gamma-Aminobutyric Acid - administration & dosage gamma-Aminobutyric Acid - pharmacology Hyperalgesia - chemically induced Hyperalgesia - metabolism Hyperalgesia - prevention & control Injections, Intraperitoneal Male mechanical allodynia Mice, Inbred Strains neuropathic pain Organoplatinum Compounds - administration & dosage Organoplatinum Compounds - adverse effects Oxaliplatin Phosphorylation - drug effects Spinal Cord - metabolism |
title | Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A20%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gabapentin%20Prevents%20Oxaliplatin-Induced%20Mechanical%20Hyperalgesia%20in%20Mice&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Ohsawa,%20Masahiro&rft.aucorp=Musashino%20University&rft.date=2014&rft.volume=125&rft.issue=3&rft.spage=292&rft.epage=299&rft.pages=292-299&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.14058FP&rft_dat=%3Cproquest_doaj_%3E1547830321%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c774t-b245577e27ca800b68a74e34e209f14f76d3cb2eebbb2f7aa1f4086f6daa3a963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1547830321&rft_id=info:pmid/24990115&rfr_iscdi=true |